Peer Review History
| Original SubmissionMay 12, 2024 |
|---|
|
Transfer Alert
This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.
Dear Professor Borges, Thank you very much for submitting your manuscript "Paracoccidioides lutzii Infects Galleria mellonella Employing Formamidase as a Virulence Factor" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments. We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation. When you are ready to resubmit, please upload the following: [1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. [2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file). Important additional instructions are given below your reviewer comments. Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts. Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments. Sincerely, Joshua Nosanchuk, MD Section Editor PLOS Neglected Tropical Diseases Joshua Nosanchuk Section Editor PLOS Neglected Tropical Diseases *********************** Reviewer's Responses to Questions Key Review Criteria Required for Acceptance? As you describe the new analyses required for acceptance, please consider the following: Methods -Are the objectives of the study clearly articulated with a clear testable hypothesis stated? -Is the study design appropriate to address the stated objectives? -Is the population clearly described and appropriate for the hypothesis being tested? -Is the sample size sufficient to ensure adequate power to address the hypothesis being tested? -Were correct statistical analysis used to support conclusions? -Are there concerns about ethical or regulatory requirements being met? Reviewer #1: The objectives of the study are clearly articulated, focusing on the role of P. lutzii formamidase during interaction with G. mellonella. The study design appears appropriate for addressing the objectives. The use of G. mellonella larvae as a model organism to study fungal-host interactions is well-founded. The manuscript provided information regarding the sample size. The authors need to clarify whether appropriate statistical analyses were conducted to support the conclusions, particularly in relation to the results presented in Figure 3. It is essential to specify the statistical methods used, and whether any comparisons between groups were made to validate the findings. Reviewer #2: Are the objectives of the study clearly articulated with a clear testable hypothesis stated? -Is the study design appropriate to address the stated objectives? YES -Is the population clearly described and appropriate for the hypothesis being tested? YES -Is the sample size sufficient to ensure adequate power to address the hypothesis being tested? YES -Were correct statistical analysis used to support conclusions? YES -Are there concerns about ethical or regulatory requirements being met? YES Additional comments on MATERIALS AND METHODS Did the authors perform a growth curve of the control and the silenced (AS-find) strain for growth rate control purposes? -------------------- Results -Does the analysis presented match the analysis plan? -Are the results clearly and completely presented? -Are the figures (Tables, Images) of sufficient quality for clarity? Reviewer #1: The results are well-presented, but there are points that need more detailed explanations. Additional information is needed regarding the construction of the AS-fmd strain and further exploration of the findings in Figures 1 and 2. Reviewer #2: -Does the analysis presented match the analysis plan? YES -Are the results clearly and completely presented? YES -Are the figures (Tables, Images) of sufficient quality for clarity? YES Additional comments on RESULTS AND DISCUSSION Fig. 1. Could the authors measure the intensity of the spots and transform it to numeric data? Also, is the formation of these melanin spots correlated to the viability of the fungus? What happens if the authors inject a non-viable wild type to G. mellonella? Could the authors perform any immunohistochemistry to accurately determine the arrangement of fungal cells in G. mellonella tissues upon infection? It is not possible to accurately visualize the number of fungal cells comparing both strains (WT x AS-find silenced). Have the authors perform any CFU experiments to determine the viable fungal loads upon infection, as melanogenesis itself has been proven to have antimicrobial activities as the authors themselves stated. What is the average of nodular tissues observed in WT x AS-find silenced infected G. melonnella? Could the authors include the data of phagocytosis and survival rates of WT x AS silenced strains upon interactions with haemocytes? What is the melanization pattern of the observed global larvae upon infection comparing both groups? Could the authors also perform a curve of melanization over time, for both groups and the controls? -------------------- Conclusions -Are the conclusions supported by the data presented? -Are the limitations of analysis clearly described? -Do the authors discuss how these data can be helpful to advance our understanding of the topic under study? -Is public health relevance addressed? Reviewer #1: The conclusions are supported by the presented data, but it would be interesting to explore the hypotheses highlighted in Figure 5 further to ensure they are fully substantiated by the results. The authors should address the public health relevance in detail. Reviewer #2: -Are the conclusions supported by the data presented? YES -Are the limitations of analysis clearly described? YES -Do the authors discuss how these data can be helpful to advance our understanding of the topic under study? YES -Is public health relevance addressed? YES -------------------- Editorial and Data Presentation Modifications? Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”. Reviewer #1: (No Response) Reviewer #2: (No Response) -------------------- Summary and General Comments Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed. Reviewer #1: Pereira et al. explore the role of P. lutzii formamidase during interaction with G. mellonella larvae. The experiments were well-executed, but some concerns need to be addressed: 1. Revise the reference formatting to correct inconsistencies throughout the manuscript. 2. Include additional information regarding the construction of the AS-fmd strain in the methods and/or results sections. 3. The authors discuss the following regarding the images in Figure 1: “The reduced intensity of dark-brown sites suggests a cellular response with lower melanogenesis compared to the wild-type (Fig. 1, J-L). These patterns of accumulation may also indicate the presence of fungal melanin (44), which only became visually apparent due to the severe nodular melanin reduction. Further analysis is needed to confirm this idea.” What specific analyses could be conducted to confirm this hypothesis? It is important to explore this possibility further in the text. 4. The results presented in Figure 2 are insufficient to confirm the role of FMD as a DAMP during fungal-host interaction. This hypothesis needs to be explored in more detail. Are there other evidences that could support this specific role? 5. The authors conclude that formamidase is associated with increased fungal burden in the nodules based on the results in Figure 3. Did the authors perform any statistical analysis to compare the groups? What strategies should be used to quantify the observed differences? 6. The abstract highlights that the authors “suggest that formamidase is a crucial step in molecular recognition by Galleria immune cells.” Please revise this sentence considering the points discussed above. Reviewer #2: Dear Editor, The manuscript by Pereira et. al. explores the participation of the P. lutzii formamidase in a model of G. mellonella infection by performing a series of histological evaluations and survival experiments comparing a wild type strain x silenced strain (AS-find) of P. lutzii. This manuscript is a nice contribution to the field, but some comments need to be addressed before its consideration for publication. Here is a point-by-point comments for every section ABSTRACT Page 5, line 8. The authors should re-write this sentence. What do they mean, the participation of formamidase or its products? INTRODUCTION Some references are in numbered format and others (AUTHORS, year). The authors should always carefully review the whole document before submission. Also, the spaces between sentences and references. What is the role of the ammonium generated by formamidase on the buffering of the pH? Please address. Could the authors test the formamidase activity of these silenced strain (AS-find), in terms of cytoplasmic extracts and also exoantigens? RESULTS AND DISCUSSION Growth rate of both strains? Hygromycin plays any pressure on the AS-find strain? RESULTS AND DISCUSSION Fig. 1. Could the authors measure the intensity of the spots and transform it to numeric data? Also, is the formation of these melanin spots correlated to the viability of the fungus? What happens if the authors inject a non-viable wild type to G. mellonella? Could the authors perform any immunohistochemistry to accurately determine the arrangement of fungal cells in G. mellonella tissues upon infection? It is not possible to accurately visualize the number of fungal cells comparing both strains (WT x AS-find silenced). Have the authors perform any CFU experiments to determine the viable fungal loads upon infection, as melanogenesis itself has been proven to have antimicrobial activities as the authors themselves stated. What is the average of nodular tissues observed in WT x AS-find silenced infected G. melonnella? Could the authors include the data of phagocytosis and survival rates of WT x AS silenced strains upon interactions with haemocytes? What is the melanization pattern of the observed global larvae upon infection comparing both groups? Could the authors also perform a curve of melanization over time, for both groups and the controls? -------------------- PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Allan J. Guimaraes Figure Files: While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Data Requirements: Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5. Reproducibility: To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols |
| Revision 1 |
|
Dear Professor Borges, Thank you for your robust response to the reviewer comments on the prior version of the manuscript. We are pleased to inform you that your manuscript 'Paracoccidioides lutzii Infects Galleria mellonella Employing Formamidase as a Virulence Factor' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases. Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests. Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated. IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript. Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS. Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases. Best regards, Joshua Nosanchuk, MD Section Editor PLOS Neglected Tropical Diseases *********************************************************** |
| Formally Accepted |
|
Dear Professor Borges, We are delighted to inform you that your manuscript, "Paracoccidioides lutzii Infects Galleria mellonella Employing Formamidase as a Virulence Factor," has been formally accepted for publication in PLOS Neglected Tropical Diseases. We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication. The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly. Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers. Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases. Best regards, Shaden Kamhawi co-Editor-in-Chief PLOS Neglected Tropical Diseases Paul Brindley co-Editor-in-Chief PLOS Neglected Tropical Diseases |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .